Gujarat Kidney & Super Speciality IPO is opening today, December 22. The company aims to raise Rs 250.80 crore from the issue. This is entirely a fresh issue of 2.20 crore shares. The company has set the IPO price band at Rs 108 – 114 per equity share. The issue will close on December 24.

Gujarat Kidney IPO: GMP

The shares of Gujarat Kidney & Super Speciality were changing hands at a premium of over 6% for the past five days. The stock was trading at Rs 121, indicating that the IPO is likely to provide a gain of Rs 896 on a single lot.

However, readers must remember that the GMP is an unofficial metric of investor sentiment. Sometimes the actual listing price can be very different from what the GMP indicates.

Gujarat Kidney IPO: Allotment and listing

The allotment for the Gujarat Kidney IPO is expected to be finalised on December 26, while the listing on the exchanges, BSE and NSE, is likely to be on December 30, as per the tentative schedule.

Gujarat Kidney IPO: Objectives of the issue

The company will be using Rs 77 crore for the acquisition of Parekhs Hospital at Ahmedabad, while it will be using Rs 12.40 crore for the payment of the already acquired ‘Ashwini Medical Centre’. Also, the company will be using Rs 30 crore for funding capital expenditure towards setting up a new hospital in Vadodara. The raised funding will also be used for the payment of certain borrowings and purchasing robotic machines for hospitals.

Gujarat Kidney IPO: Lot size

A retail applicant needs to apply for a minimum of one lot of 128 shares, amounting to Rs 14,592. The lot size investment for a small non-institutional investor (NII) is 14 lots of 1,792 shares, aggregating to Rs 2 lakh, and for a big NII, it is 69 lots of 8,832 shares, totalling to Rs 10 lakh.

Gujarat Kidney IPO: Book runner and registrar

Nirbhay Capital Services is the book-running lead manager for the IPO, and MUFG Intime India is the registrar of the issue.

About Gujarat Kidney & Super Speciality

Gujarat Kidney and Super Speciality specialises in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company, incorporated in 2019, operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.